YTHDC2 inhibited DNA damage repair induced by Ultraviolet B by inhibiting the expression of the tumor suppressor gene PTEN, suggesting its potential upregulation could serve as a biomarker for cSCC [65]. Here, YTHDC2 is linked to skin squamous cell carcinoma.